ALL 市場調査レポート

このリストでは当社が提供する全市場調査レポートを新刊順に紹介しています。
通信・IT、環境・エネルギー・自動車だけでなく、医薬、医療、産業機械、電子部品/半導体、マテリアルを始めとして、運輸、金融・保険、農業・林業、消費財、不動産、宇宙・防衛、食品、小売業、サービス業等に関する調査レポート(技術動向、市場規模予測)を紹介しています。

敗血性ショック (その他の疾患) - 開発段階の治療薬　2021年

Septic Shock (Other Diseases) - Drugs in Development, 2021

価格　US$ 2,000　｜　 Global Markets Direct　｜　―

Septic Shock (Other Diseases) - Drugs in Development, 2021SummarySeptic Shock (Other Diseases) - Drugs in Development, 2021 provides an overview of the Septic Shock pipeline landscape.The report provides comprehensive information on the therapeutics under…

このレポートの詳細ページはこちら

敗血症 (感染性疾患) - 開発段階の治療薬　2021年

Sepsis (Infectious Disease) - Drugs in Development, 2021

価格　US$ 2,500　｜　 Global Markets Direct　｜　―

Sepsis (Infectious Disease) - Drugs in Development, 2021SummarySepsis (Infectious Disease) - Drugs in Development, 2021 provides an overview of the Sepsis pipeline landscape.The report provides comprehensive information on the therapeutics under developme…

このレポートの詳細ページはこちら

脳内出血 (中枢神経系) - 開発段階の治療薬　2021年

Brain Hemorrhage (Central Nervous System) - Drugs in Development, 2021

価格　US$ 2,000　｜　 Global Markets Direct　｜　―

Brain Hemorrhage (Central Nervous System) - Drugs in Development, 2021SummaryBrain Hemorrhage (Central Nervous System) - Drugs in Development, 2021 provides an overview of the Brain Hemorrhage pipeline landscape.The report provides comprehensive informati…

このレポートの詳細ページはこちら

脳腫瘍 (腫瘍学) - 開発段階の治療薬　2021年

Brain Cancer (Oncology) - Drugs in Development, 2021

価格　US$ 2,000　｜　 Global Markets Direct　｜　―

Brain Cancer (Oncology) - Drugs in Development, 2021SummaryBrain Cancer (Oncology) - Drugs in Development, 2021 provides an overview of the Brain Cancer pipeline landscape.The report provides comprehensive information on the therapeutics under development…

このレポートの詳細ページはこちら

脳梗塞 (中枢神経系) - 開発段階の治療薬　2021年

Cerebral Infarction (Brain Infarction) (Central Nervous System) - Drugs in Development, 2021

価格　US$ 2,000　｜　 Global Markets Direct　｜　―

Cerebral Infarction (Brain Infarction) (Central Nervous System) - Drugs in Development, 2021SummaryCerebral Infarction (Brain Infarction) (Central Nervous System) - Drugs in Development, 2021 provides an overview of the Cerebral Infarction (Brain Infarcti…

このレポートの詳細ページはこちら

認識機能障害 (中枢神経系) - 開発段階の治療薬　2021年

Cognitive Impairment (Central Nervous System) - Drugs in Development, 2021

価格　US$ 2,000　｜　 Global Markets Direct　｜　―

Cognitive Impairment (Central Nervous System) - Drugs in Development, 2021SummaryCognitive Impairment (Central Nervous System) - Drugs in Development, 2021 provides an overview of the Cognitive Impairment pipeline landscape.The report provides comprehensi…

このレポートの詳細ページはこちら

尿路感染症 (感染性疾患) - 開発段階の治療薬　2021年

Urinary Tract Infections (Infectious Disease) - Drugs in Development, 2021

価格　US$ 2,000　｜　 Global Markets Direct　｜　―

Urinary Tract Infections (Infectious Disease) - Drugs in Development, 2021SummaryUrinary Tract Infections (Infectious Disease) - Drugs in Development, 2021 provides an overview of the Urinary Tract Infections pipeline landscape.The report provides compreh…

このレポートの詳細ページはこちら

二次性進行型多発性硬化症 (SPMS) (中枢神経系) - 開発段階の治療薬　2021年

Secondary Progressive Multiple Sclerosis (SPMS) (Central Nervous System) - Drugs in Development, 2021

価格　US$ 2,000　｜　 Global Markets Direct　｜　―

Secondary Progressive Multiple Sclerosis (SPMS) (Central Nervous System) - Drugs in Development, 2021SummarySecondary Progressive Multiple Sclerosis (SPMS) (Central Nervous System) - Drugs in Development, 2021 provides an overview of the Secondary Progres…

このレポートの詳細ページはこちら

難治性慢性リンパ球性白血病 (CLL) (腫瘍学) - 開発段階の治療薬　2021年

Refractory Chronic Lymphocytic Leukemia (CLL) (Oncology) - Drugs in Development, 2021

価格　US$ 2,000　｜　 Global Markets Direct　｜　―

Refractory Chronic Lymphocytic Leukemia (CLL) (Oncology) - Drugs in Development, 2021SummaryRefractory Chronic Lymphocytic Leukemia (CLL) (Oncology) - Drugs in Development, 2021 provides an overview of the Refractory Chronic Lymphocytic Leukemia (CLL) pip…

このレポートの詳細ページはこちら

難治性急性骨髄性白血病 (腫瘍学) - 開発段階の治療薬　2021年

Refractory Acute Myeloid Leukemia (Oncology) - Drugs in Development, 2021

価格　US$ 2,500　｜　 Global Markets Direct　｜　―

Refractory Acute Myeloid Leukemia (Oncology) - Drugs in Development, 2021SummaryRefractory Acute Myeloid Leukemia (Oncology) - Drugs in Development, 2021 provides an overview of the Refractory Acute Myeloid Leukemia pipeline landscape.The report provides …

このレポートの詳細ページはこちら

内臓痛 (中枢神経系) - 開発段階の治療薬　2021年

Visceral Pain (Central Nervous System) - Drugs in Development, 2021

価格　US$ 2,000　｜　 Global Markets Direct　｜　―

Visceral Pain (Central Nervous System) - Drugs in Development, 2021SummaryVisceral Pain (Central Nervous System) - Drugs in Development, 2021 provides an overview of the Visceral Pain pipeline landscape.The report provides comprehensive information on the…

このレポートの詳細ページはこちら

糖尿病性神経障害に伴う疼痛 (中枢神経系) - 開発段階の治療薬　2021年

Diabetic Neuropathic Pain (Central Nervous System) - Drugs in Development, 2021

価格　US$ 2,000　｜　 Global Markets Direct　｜　―

Diabetic Neuropathic Pain (Central Nervous System) - Drugs in Development, 2021SummaryDiabetic Neuropathic Pain (Central Nervous System) - Drugs in Development, 2021 provides an overview of the Diabetic Neuropathic Pain pipeline landscape.The report provi…

このレポートの詳細ページはこちら

転移性膵臓腺がん (腫瘍学) - 開発段階の治療薬　2021年

Metastatic Adenocarcinoma of The Pancreas (Oncology) - Drugs in Development, 2021

価格　US$ 2,000　｜　 Global Markets Direct　｜　―

Metastatic Adenocarcinoma of The Pancreas (Oncology) - Drugs in Development, 2021SummaryMetastatic Adenocarcinoma of The Pancreas (Oncology) - Drugs in Development, 2021 provides an overview of the Metastatic Adenocarcinoma of The Pancreas pipeline landsc…

このレポートの詳細ページはこちら

転移性膵がん (腫瘍学) - 開発段階の治療薬　2021年

Metastatic Pancreatic Cancer (Oncology) - Drugs in Development, 2021

価格　US$ 2,000　｜　 Global Markets Direct　｜　―

Metastatic Pancreatic Cancer (Oncology) - Drugs in Development, 2021SummaryMetastatic Pancreatic Cancer (Oncology) - Drugs in Development, 2021 provides an overview of the Metastatic Pancreatic Cancer pipeline landscape.The report provides comprehensive i…

このレポートの詳細ページはこちら

転移性卵巣がん (腫瘍学) - 開発段階の治療薬　2021年

Metastatic Ovarian Cancer (Oncology) - Drugs in Development, 2021

価格　US$ 2,000　｜　 Global Markets Direct　｜　―

Metastatic Ovarian Cancer (Oncology) - Drugs in Development, 2021SummaryMetastatic Ovarian Cancer (Oncology) - Drugs in Development, 2021 provides an overview of the Metastatic Ovarian Cancer pipeline landscape.The report provides comprehensive informatio…

このレポートの詳細ページはこちら

転移性前立腺がん (腫瘍学) - 開発段階の治療薬　2021年

Metastatic Prostate Cancer (Oncology) - Drugs in Development, 2021

価格　US$ 2,000　｜　 Global Markets Direct　｜　―

Metastatic Prostate Cancer (Oncology) - Drugs in Development, 2021SummaryMetastatic Prostate Cancer (Oncology) - Drugs in Development, 2021 provides an overview of the Metastatic Prostate Cancer pipeline landscape.The report provides comprehensive informa…

このレポートの詳細ページはこちら

転移性腎細胞がん (腫瘍学) - 開発段階の治療薬　2021年

Metastatic Renal Cell Carcinoma (Oncology) - Drugs in Development, 2021

価格　US$ 2,000　｜　 Global Markets Direct　｜　―

Metastatic Renal Cell Carcinoma (Oncology) - Drugs in Development, 2021SummaryMetastatic Renal Cell Carcinoma (Oncology) - Drugs in Development, 2021 provides an overview of the Metastatic Renal Cell Carcinoma pipeline landscape.The report provides compre…

このレポートの詳細ページはこちら

転移性黒色腫 (腫瘍学) - 開発段階の治療薬　2021年

Metastatic Melanoma (Oncology) - Drugs in Development, 2021

価格　US$ 2,500　｜　 Global Markets Direct　｜　―

Metastatic Melanoma (Oncology) - Drugs in Development, 2021SummaryMetastatic Melanoma (Oncology) - Drugs in Development, 2021 provides an overview of the Metastatic Melanoma pipeline landscape.The report provides comprehensive information on the therapeut…

このレポートの詳細ページはこちら

鳥インフルエンザ (感染性疾患) - 開発段階の治療薬　2021年

Avian Influenza (Infectious Disease) - Drugs in Development, 2021

価格　US$ 2,000　｜　 Global Markets Direct　｜　―

Avian Influenza (Infectious Disease) - Drugs in Development, 2021SummaryAvian Influenza (Infectious Disease) - Drugs in Development, 2021 provides an overview of the Avian Influenza pipeline landscape.The report provides comprehensive information on the t…

このレポートの詳細ページはこちら

腸炎 (胃腸) - 開発段階の治療薬　2021年

Enteritis (Gastrointestinal) - Drugs in Development, 2021

価格　US$ 2,000　｜　 Global Markets Direct　｜　―

Enteritis (Gastrointestinal) - Drugs in Development, 2021SummaryEnteritis (Gastrointestinal) - Drugs in Development, 2021 provides an overview of the Enteritis pipeline landscape.The report provides comprehensive information on the therapeutics under deve…

このレポートの詳細ページはこちら